Aarti Drugs Limited has informed the Exchange about Schedule of meet
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aarti Drugs Limited has scheduled an earnings conference call for Monday, May 18, 2026 at 11:00 AM IST to discuss the company's financial performance for the quarter ended March 31, 2026 (Q4 FY26). The call will feature senior leadership including Mr. Harshit Savla (Jt. Managing Director), Mr. Harit Shah (Whole time Director), Mr. Adhish Patil (CFO & COO), and Mr. Vishwa Savla (MD, Pinnacle Life Science). The company has engaged Strategic Growth Advisors Pvt. Ltd. for logistics and investor coordination. Dial-in details for multiple countries including India, US, UK, Singapore, and Hong Kong have been provided.
This routine investor engagement event signals ongoing communication with the market. While not directly price-sensitive, the call may provide insights into Q4 performance and FY26 outlook, which could influence analyst views and investor sentiment.